Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARTELS E. C. Clinical experience with a new antithyroid drug: 2-carbethoxythio-1-methylglyoxaline. J Clin Endocrinol Metab. 1953 Nov;13(11):1305–1311. doi: 10.1210/jcem-13-11-1305. [DOI] [PubMed] [Google Scholar]
- BURRELL C. D., FRASER R., DONIACH D. The low toxicity of carbimazole; a survey of 1,046 patients. Br Med J. 1956 Jun 23;1(4981):1453–1456. doi: 10.1136/bmj.1.4981.1453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FRASER T. R., GARROD O., HANNO M. G., JADRESIC A. Antithyroid activity and toxicity of mercazole and neo-mercazole. J Clin Endocrinol Metab. 1954 Oct;14(10):1230–1244. doi: 10.1210/jcem-14-10-1230. [DOI] [PubMed] [Google Scholar]
- GREENE R., MORGAN D. C. Toxicity of the antithyroid drug carbimazole. J Clin Endocrinol Metab. 1956 Mar;16(3):391–396. doi: 10.1210/jcem-16-3-391. [DOI] [PubMed] [Google Scholar]
- HARRISON A. R. Agranulocytosis in a patient treated with carbimazole. Lancet. 1954 Feb 20;266(6808):396–396. doi: 10.1016/s0140-6736(54)90931-9. [DOI] [PubMed] [Google Scholar]
- RICHARDSON J. S., SARKANY I., CAMPBELL C. D. Fatal case of marrow aplasia after treatment with carbimazole; the effect of ACTH. Br Med J. 1954 Feb 13;1(4858):364–365. doi: 10.1136/bmj.1.4858.364. [DOI] [PMC free article] [PubMed] [Google Scholar]